Woman Alleges Permanent Alopecia after Using Taxotere Chemotherapy Drug
Sanofi-Aventis is facing another lawsuit over its chemotherapy drug, Taxotere. A woman alleges that the company failed to warn about the risk of permanent alopecia, or hair loss, after taking Taxotere. She alleges that the company misled her and her oncologist about the risks of Taxotere and claims that she would have chosen a … [Read more...]
New Mexico AG Files Lawsuit Against Plavix Manufacturers
The New Mexico Attorney General has filed a lawsuit against Bristol-Myers Squibb, the manufacturer of Plavix, alleging that the company failed to warn of risks associated with the blood thinner. The suit alleges that the pharmaceutical giant deceived New Mexicans by failing to warn about the increased risk of internal bleeding. The … [Read more...]
Sanofi Faces Another Lawsuit over Taxotere
Sanofi-Aventis faces another lawsuit alleging that its chemotherapy drug Taxotere led to permanent hair loss, or alopecia. The suit accuses the drug maker of failing to adequately warn about the risk of irreversible hair loss. The plaintiff is a California woman who was diagnosed with Stage II breast cancer in 2010. She underwent six … [Read more...]
Taxotere and the Risk of Alopecia
The U.S. Food and Drug Administration (FDA) approved Taxotere as a chemotherapy drug in 1996. Taxotere is manufactured by Sanofi-Aventis and is commonly used to treat breast cancer, as well as other cancers. Some patients taking Taxotere have reported experiencing permanent hair loss, or alopecia. In December 2015, the FDA warned … [Read more...]
Acomplia a Loser for Sanofi-Aventis
Weight-Loss Drug Acomplia Adverse Reactions. Five lives have been claimed and 720 adverse drug reactions have occurred in Britain since the launch of France’s Sanofi-Aventis SA's weight-loss drug, Acomplia, two years ago; this, according to a posting on the United Kingdom’s drug regulator’s Website this week. Acomplia—known … [Read more...]
Ketek Lawsuit Filed in Illinois
Ketek Lawsuit Filed in Illinois. Ketek users injured by the defective drug have filed suit against Sanofi-Aventis in Illinois. The 47 plaintiffs involved in the Ketek lawsuit claim that Sanofi-Aventis knew that Ketek put users at an increased risk of increased risk injuries or death from liver failure and hepatic … [Read more...]
